Brenda Beaty
Concepts (525)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 58 | 2025 | 1348 | 3.060 |
Why?
| Practice Patterns, Physicians' | 37 | 2025 | 1266 | 1.940 |
Why?
| Attitude of Health Personnel | 34 | 2021 | 1098 | 1.790 |
Why?
| Physicians, Primary Care | 14 | 2021 | 230 | 1.620 |
Why?
| Immunization | 20 | 2021 | 411 | 1.430 |
Why?
| Influenza Vaccines | 24 | 2021 | 532 | 1.400 |
Why?
| Reminder Systems | 13 | 2021 | 174 | 1.220 |
Why?
| Immunization Programs | 18 | 2020 | 214 | 1.150 |
Why?
| Vaccines | 15 | 2021 | 398 | 1.150 |
Why?
| Health Knowledge, Attitudes, Practice | 24 | 2021 | 1279 | 1.140 |
Why?
| Papillomavirus Vaccines | 12 | 2021 | 232 | 1.040 |
Why?
| Pediatrics | 24 | 2021 | 1052 | 1.010 |
Why?
| Influenza, Human | 18 | 2021 | 601 | 1.000 |
Why?
| Physicians, Family | 13 | 2021 | 207 | 0.940 |
Why?
| Pediatricians | 8 | 2022 | 129 | 0.870 |
Why?
| Primary Health Care | 22 | 2021 | 1680 | 0.860 |
Why?
| Papillomavirus Infections | 8 | 2021 | 297 | 0.730 |
Why?
| Pneumococcal Vaccines | 8 | 2021 | 140 | 0.680 |
Why?
| Vaccination Refusal | 5 | 2021 | 70 | 0.670 |
Why?
| Health Care Surveys | 19 | 2025 | 559 | 0.650 |
Why?
| Stifle | 1 | 2019 | 4 | 0.640 |
Why?
| Patellar Ligament | 1 | 2019 | 25 | 0.630 |
Why?
| Dog Diseases | 1 | 2019 | 52 | 0.610 |
Why?
| Anterior Cruciate Ligament | 1 | 2019 | 80 | 0.610 |
Why?
| Osteotomy | 1 | 2019 | 99 | 0.600 |
Why?
| Herpes Zoster Vaccine | 6 | 2022 | 162 | 0.590 |
Why?
| Surveys and Questionnaires | 35 | 2025 | 5406 | 0.580 |
Why?
| Mumps | 3 | 2023 | 24 | 0.580 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2019 | 140 | 0.550 |
Why?
| Humans | 161 | 2025 | 129650 | 0.490 |
Why?
| Female | 107 | 2025 | 68776 | 0.480 |
Why?
| Family Practice | 11 | 2017 | 455 | 0.470 |
Why?
| Male | 97 | 2025 | 63681 | 0.460 |
Why?
| Parents | 11 | 2025 | 1309 | 0.460 |
Why?
| Patient Acceptance of Health Care | 8 | 2025 | 759 | 0.450 |
Why?
| United States | 48 | 2025 | 13903 | 0.450 |
Why?
| Physicians | 11 | 2022 | 865 | 0.440 |
Why?
| Herpes Zoster | 4 | 2022 | 317 | 0.440 |
Why?
| Wounds and Injuries | 4 | 2024 | 711 | 0.430 |
Why?
| Rotavirus Vaccines | 4 | 2021 | 49 | 0.430 |
Why?
| Viral Vaccines | 2 | 2025 | 94 | 0.420 |
Why?
| Immunization Schedule | 6 | 2021 | 197 | 0.420 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2019 | 92 | 0.410 |
Why?
| Insurance, Health, Reimbursement | 6 | 2018 | 94 | 0.410 |
Why?
| Rubella | 2 | 2023 | 23 | 0.400 |
Why?
| Adult | 61 | 2025 | 35576 | 0.400 |
Why?
| Middle Aged | 57 | 2024 | 31154 | 0.390 |
Why?
| Liver Transplantation | 4 | 2025 | 831 | 0.390 |
Why?
| Measles | 2 | 2023 | 44 | 0.390 |
Why?
| Terminally Ill | 3 | 2007 | 35 | 0.390 |
Why?
| Rotavirus Infections | 4 | 2021 | 45 | 0.380 |
Why?
| Mobile Applications | 2 | 2025 | 160 | 0.360 |
Why?
| Infant | 38 | 2025 | 9024 | 0.350 |
Why?
| Colorado | 33 | 2020 | 4421 | 0.340 |
Why?
| Meningococcal Vaccines | 4 | 2018 | 54 | 0.330 |
Why?
| Hypertension | 7 | 2016 | 1242 | 0.330 |
Why?
| Child | 42 | 2025 | 20883 | 0.330 |
Why?
| Community Health Services | 4 | 2017 | 227 | 0.330 |
Why?
| Pregnancy Complications, Infectious | 3 | 2020 | 367 | 0.310 |
Why?
| Anesthesia, Obstetrical | 2 | 1998 | 6 | 0.290 |
Why?
| Organ Transplantation | 2 | 2023 | 228 | 0.290 |
Why?
| Stress, Psychological | 4 | 2014 | 1066 | 0.280 |
Why?
| Gynecology | 3 | 2019 | 175 | 0.280 |
Why?
| Hospitalization | 6 | 2020 | 2070 | 0.260 |
Why?
| Emergency Medical Services | 2 | 2023 | 522 | 0.260 |
Why?
| Internal Medicine | 5 | 2014 | 247 | 0.260 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2018 | 120 | 0.260 |
Why?
| Child, Preschool | 28 | 2025 | 10517 | 0.260 |
Why?
| Clinical Competence | 3 | 2018 | 1017 | 0.250 |
Why?
| Practice Guidelines as Topic | 10 | 2021 | 1501 | 0.240 |
Why?
| Delivery of Health Care | 6 | 2023 | 894 | 0.240 |
Why?
| Insurance, Health | 5 | 2016 | 267 | 0.230 |
Why?
| Urban Population | 4 | 2017 | 441 | 0.220 |
Why?
| Adolescent | 28 | 2023 | 20393 | 0.220 |
Why?
| Professional-Family Relations | 2 | 2016 | 145 | 0.220 |
Why?
| Physician-Patient Relations | 3 | 2019 | 539 | 0.220 |
Why?
| Aged | 29 | 2021 | 22103 | 0.220 |
Why?
| Pneumococcal Infections | 3 | 2018 | 110 | 0.220 |
Why?
| Multivariate Analysis | 13 | 2020 | 1502 | 0.220 |
Why?
| Freeze Drying | 1 | 2024 | 82 | 0.210 |
Why?
| Cohort Studies | 19 | 2023 | 5420 | 0.210 |
Why?
| Adolescent Health Services | 3 | 2015 | 76 | 0.210 |
Why?
| General Practitioners | 2 | 2021 | 26 | 0.210 |
Why?
| Shock, Traumatic | 1 | 2023 | 14 | 0.210 |
Why?
| South Africa | 4 | 2024 | 192 | 0.200 |
Why?
| Child Health Services | 5 | 2007 | 185 | 0.200 |
Why?
| Chickenpox | 1 | 2023 | 80 | 0.200 |
Why?
| Registries | 10 | 2022 | 1896 | 0.200 |
Why?
| Attitude to Health | 2 | 2017 | 431 | 0.200 |
Why?
| Plasma | 1 | 2024 | 206 | 0.200 |
Why?
| Vaccines, Synthetic | 2 | 2022 | 126 | 0.190 |
Why?
| Text Messaging | 2 | 2022 | 149 | 0.190 |
Why?
| Pain | 3 | 2009 | 789 | 0.190 |
Why?
| Data Collection | 12 | 2014 | 650 | 0.190 |
Why?
| Health Promotion | 5 | 2015 | 719 | 0.190 |
Why?
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.190 |
Why?
| Insurance Coverage | 5 | 2018 | 219 | 0.180 |
Why?
| Prisoners | 2 | 2014 | 141 | 0.180 |
Why?
| Follow-Up Studies | 8 | 2019 | 4897 | 0.180 |
Why?
| Alphapapillomavirus | 1 | 2021 | 40 | 0.180 |
Why?
| Hepatitis B Vaccines | 3 | 2010 | 47 | 0.180 |
Why?
| Sexually Transmitted Diseases | 3 | 2013 | 150 | 0.180 |
Why?
| Health Care Costs | 2 | 2017 | 367 | 0.180 |
Why?
| Treatment Refusal | 2 | 2015 | 89 | 0.180 |
Why?
| Refusal to Treat | 1 | 2020 | 17 | 0.170 |
Why?
| Emergency Service, Hospital | 4 | 2023 | 1902 | 0.170 |
Why?
| Retrospective Studies | 19 | 2023 | 14518 | 0.170 |
Why?
| Standing Orders | 1 | 2020 | 11 | 0.170 |
Why?
| Health Services Accessibility | 6 | 2019 | 902 | 0.170 |
Why?
| Breast Feeding | 4 | 2022 | 424 | 0.170 |
Why?
| Norovirus | 1 | 2020 | 23 | 0.160 |
Why?
| Advisory Committees | 1 | 2021 | 216 | 0.160 |
Why?
| Resuscitation Orders | 1 | 2020 | 46 | 0.160 |
Why?
| Hemorrhage | 1 | 2024 | 678 | 0.160 |
Why?
| Cost-Benefit Analysis | 7 | 2019 | 569 | 0.160 |
Why?
| Policy | 1 | 2020 | 144 | 0.160 |
Why?
| Obstetrics | 2 | 2019 | 161 | 0.160 |
Why?
| Prospective Studies | 11 | 2024 | 7133 | 0.160 |
Why?
| State Health Plans | 3 | 2005 | 32 | 0.160 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2016 | 100 | 0.160 |
Why?
| Gastroenteritis | 1 | 2020 | 67 | 0.160 |
Why?
| Internet | 7 | 2019 | 617 | 0.150 |
Why?
| Antihypertensive Agents | 3 | 2012 | 485 | 0.150 |
Why?
| School Health Services | 3 | 2012 | 233 | 0.150 |
Why?
| Pneumonia, Aspiration | 1 | 1998 | 18 | 0.150 |
Why?
| Blood Vessels | 2 | 2016 | 187 | 0.150 |
Why?
| Vaccines, Attenuated | 3 | 2025 | 125 | 0.150 |
Why?
| Public Health Practice | 2 | 2012 | 64 | 0.150 |
Why?
| Echocardiography, Stress | 1 | 2018 | 20 | 0.150 |
Why?
| Respiratory Syncytial Virus Vaccines | 1 | 2018 | 34 | 0.150 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 146 | 0.150 |
Why?
| Patient Participation | 2 | 2012 | 414 | 0.150 |
Why?
| Health Services Research | 5 | 2018 | 391 | 0.150 |
Why?
| Myocardial Perfusion Imaging | 1 | 2018 | 36 | 0.150 |
Why?
| Hospital Costs | 1 | 2019 | 114 | 0.150 |
Why?
| Meningococcal Infections | 1 | 2018 | 24 | 0.150 |
Why?
| Postoperative Period | 1 | 2019 | 329 | 0.150 |
Why?
| Dogs | 1 | 2019 | 381 | 0.150 |
Why?
| Automobile Driver Examination | 1 | 2017 | 9 | 0.140 |
Why?
| Chronic Disease | 7 | 2016 | 1720 | 0.140 |
Why?
| Tibia | 1 | 2019 | 170 | 0.140 |
Why?
| Professional Practice | 1 | 2018 | 63 | 0.140 |
Why?
| Public Health | 4 | 2015 | 484 | 0.140 |
Why?
| Herpesvirus 3, Human | 2 | 2019 | 331 | 0.140 |
Why?
| Private Practice | 3 | 2012 | 21 | 0.140 |
Why?
| Hepatitis A | 1 | 2017 | 25 | 0.130 |
Why?
| Guideline Adherence | 5 | 2016 | 526 | 0.130 |
Why?
| Cross Infection | 1 | 2019 | 218 | 0.130 |
Why?
| Croup | 1 | 2017 | 26 | 0.130 |
Why?
| Myocardial Ischemia | 1 | 2018 | 258 | 0.130 |
Why?
| Kidney Transplantation | 1 | 2023 | 672 | 0.130 |
Why?
| Information Systems | 1 | 2016 | 61 | 0.130 |
Why?
| Regression Analysis | 6 | 2020 | 993 | 0.130 |
Why?
| Physician's Role | 2 | 2019 | 206 | 0.130 |
Why?
| Infant Mortality | 1 | 1997 | 104 | 0.130 |
Why?
| Heart Arrest | 1 | 2020 | 321 | 0.130 |
Why?
| Biomechanical Phenomena | 1 | 2019 | 764 | 0.130 |
Why?
| Cross-Sectional Studies | 10 | 2024 | 5066 | 0.130 |
Why?
| Health Resources | 1 | 2017 | 114 | 0.130 |
Why?
| Mothers | 3 | 2022 | 729 | 0.130 |
Why?
| Program Evaluation | 3 | 2017 | 875 | 0.120 |
Why?
| Vaccination Coverage | 1 | 2016 | 79 | 0.120 |
Why?
| Directive Counseling | 1 | 2016 | 46 | 0.120 |
Why?
| Survival Rate | 5 | 2020 | 1877 | 0.120 |
Why?
| Health Information Systems | 1 | 2015 | 18 | 0.120 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 90 | 0.120 |
Why?
| Age Factors | 7 | 2021 | 3144 | 0.120 |
Why?
| Local Government | 1 | 2015 | 28 | 0.120 |
Why?
| Ultrasonography | 1 | 2019 | 716 | 0.120 |
Why?
| Documentation | 2 | 2015 | 184 | 0.120 |
Why?
| Risk Assessment | 5 | 2017 | 3240 | 0.120 |
Why?
| Quality Assurance, Health Care | 3 | 2007 | 318 | 0.120 |
Why?
| Computers, Handheld | 1 | 2015 | 23 | 0.120 |
Why?
| Risk-Taking | 3 | 2013 | 347 | 0.120 |
Why?
| Heart Septum | 1 | 2015 | 27 | 0.120 |
Why?
| Ablation Techniques | 1 | 2015 | 33 | 0.120 |
Why?
| Cause of Death | 1 | 1997 | 393 | 0.120 |
Why?
| Heart Block | 1 | 2015 | 40 | 0.120 |
Why?
| Communicable Diseases | 1 | 2017 | 147 | 0.120 |
Why?
| Rural Population | 3 | 2014 | 518 | 0.110 |
Why?
| Diagnostic Tests, Routine | 1 | 2015 | 102 | 0.110 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 138 | 0.110 |
Why?
| Streptococcal Vaccines | 1 | 2014 | 6 | 0.110 |
Why?
| Medically Uninsured | 4 | 2014 | 127 | 0.110 |
Why?
| Preventive Health Services | 1 | 2016 | 145 | 0.110 |
Why?
| Young Adult | 12 | 2020 | 12426 | 0.110 |
Why?
| Gastroenterology | 1 | 2016 | 174 | 0.110 |
Why?
| Risk Factors | 13 | 2017 | 9765 | 0.110 |
Why?
| Public-Private Sector Partnerships | 1 | 2014 | 42 | 0.110 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 132 | 0.110 |
Why?
| SEER Program | 2 | 2012 | 206 | 0.110 |
Why?
| Clinical Decision-Making | 3 | 2021 | 303 | 0.100 |
Why?
| Inpatients | 1 | 2017 | 467 | 0.100 |
Why?
| Patient Selection | 2 | 2007 | 663 | 0.100 |
Why?
| Neonatal Screening | 1 | 2014 | 163 | 0.100 |
Why?
| Disease Outbreaks | 3 | 2022 | 349 | 0.100 |
Why?
| Suicide, Attempted | 1 | 2016 | 349 | 0.100 |
Why?
| Quality of Life | 4 | 2008 | 2704 | 0.100 |
Why?
| Palliative Care | 3 | 2008 | 725 | 0.100 |
Why?
| Health Education | 1 | 2015 | 334 | 0.100 |
Why?
| Pregnancy | 8 | 2020 | 6402 | 0.100 |
Why?
| Disease Management | 2 | 2017 | 589 | 0.100 |
Why?
| Cardiovascular Diseases | 2 | 2017 | 2004 | 0.100 |
Why?
| Electronic Mail | 3 | 2018 | 60 | 0.100 |
Why?
| Referral and Consultation | 2 | 2014 | 732 | 0.100 |
Why?
| Streptococcal Infections | 1 | 2014 | 148 | 0.090 |
Why?
| Atherosclerosis | 1 | 2016 | 402 | 0.090 |
Why?
| Hyperlipidemias | 1 | 2012 | 126 | 0.090 |
Why?
| Blood Pressure | 2 | 2016 | 1736 | 0.090 |
Why?
| Developmental Disabilities | 1 | 2014 | 261 | 0.090 |
Why?
| Attitude | 2 | 2021 | 253 | 0.090 |
Why?
| Craniopharyngioma | 1 | 2012 | 82 | 0.090 |
Why?
| Poverty | 6 | 2017 | 496 | 0.090 |
Why?
| Continuity of Patient Care | 1 | 2013 | 275 | 0.090 |
Why?
| Infant, Newborn | 9 | 2021 | 5762 | 0.090 |
Why?
| Critical Pathways | 1 | 2012 | 80 | 0.090 |
Why?
| Condoms | 2 | 2009 | 103 | 0.090 |
Why?
| Acculturation | 1 | 2011 | 50 | 0.090 |
Why?
| Safety | 1 | 2013 | 331 | 0.090 |
Why?
| Suicidal Ideation | 1 | 2016 | 463 | 0.090 |
Why?
| Patients | 2 | 2018 | 167 | 0.090 |
Why?
| Pituitary Neoplasms | 1 | 2012 | 184 | 0.090 |
Why?
| Interviews as Topic | 5 | 2014 | 717 | 0.090 |
Why?
| Licensure, Medical | 1 | 2010 | 14 | 0.090 |
Why?
| Vascular Stiffness | 1 | 2015 | 467 | 0.090 |
Why?
| Seasons | 4 | 2020 | 502 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 150 | 0.090 |
Why?
| Albuterol | 1 | 2011 | 103 | 0.090 |
Why?
| Drug Recalls | 1 | 2010 | 5 | 0.090 |
Why?
| Ethanol | 1 | 2015 | 589 | 0.080 |
Why?
| Haemophilus Vaccines | 1 | 2010 | 28 | 0.080 |
Why?
| Medicare Part D | 1 | 2010 | 24 | 0.080 |
Why?
| Firearms | 1 | 2016 | 359 | 0.080 |
Why?
| Audiovisual Aids | 1 | 2009 | 13 | 0.080 |
Why?
| Child Abuse | 1 | 2015 | 517 | 0.080 |
Why?
| Haemophilus Infections | 1 | 2010 | 39 | 0.080 |
Why?
| Polysaccharides, Bacterial | 1 | 2010 | 67 | 0.080 |
Why?
| Evidence-Based Medicine | 3 | 2020 | 718 | 0.080 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.080 |
Why?
| Haemophilus influenzae | 1 | 2010 | 63 | 0.080 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2015 | 1368 | 0.080 |
Why?
| Family Nursing | 1 | 2009 | 13 | 0.080 |
Why?
| Neoplasms | 3 | 2009 | 2470 | 0.080 |
Why?
| Practice Management, Medical | 1 | 2009 | 36 | 0.080 |
Why?
| Public Assistance | 1 | 2009 | 21 | 0.080 |
Why?
| Costs and Cost Analysis | 3 | 2018 | 201 | 0.080 |
Why?
| Computer-Assisted Instruction | 1 | 2009 | 60 | 0.080 |
Why?
| Social Class | 2 | 2009 | 257 | 0.080 |
Why?
| Research Design | 1 | 2015 | 1044 | 0.080 |
Why?
| Patient-Centered Care | 2 | 2013 | 505 | 0.080 |
Why?
| Bronchodilator Agents | 1 | 2011 | 243 | 0.080 |
Why?
| Incidence | 5 | 2017 | 2644 | 0.080 |
Why?
| User-Computer Interface | 1 | 2009 | 149 | 0.080 |
Why?
| Sexual Behavior | 2 | 2013 | 483 | 0.080 |
Why?
| Quality Improvement | 2 | 2014 | 1103 | 0.080 |
Why?
| Aged, 80 and over | 5 | 2020 | 7086 | 0.080 |
Why?
| Patient Access to Records | 2 | 2005 | 20 | 0.080 |
Why?
| Pain Management | 2 | 2009 | 327 | 0.080 |
Why?
| Hepatitis B | 1 | 2009 | 63 | 0.080 |
Why?
| Time Factors | 8 | 2012 | 6556 | 0.080 |
Why?
| Condoms, Female | 1 | 2008 | 2 | 0.080 |
Why?
| Logistic Models | 6 | 2012 | 1988 | 0.080 |
Why?
| Social Marketing | 1 | 2008 | 13 | 0.070 |
Why?
| Health Services Needs and Demand | 2 | 2007 | 264 | 0.070 |
Why?
| Substance-Related Disorders | 2 | 2014 | 1022 | 0.070 |
Why?
| Prostatic Neoplasms | 2 | 2006 | 1016 | 0.070 |
Why?
| Reproductive Medicine | 1 | 2008 | 15 | 0.070 |
Why?
| Fetus | 2 | 2004 | 773 | 0.070 |
Why?
| Massage | 1 | 2008 | 43 | 0.070 |
Why?
| Quality of Health Care | 2 | 2005 | 608 | 0.070 |
Why?
| Neuralgia, Postherpetic | 1 | 2008 | 40 | 0.070 |
Why?
| Algorithms | 1 | 2015 | 1622 | 0.070 |
Why?
| Complementary Therapies | 1 | 2009 | 87 | 0.070 |
Why?
| Sentinel Surveillance | 1 | 2008 | 41 | 0.070 |
Why?
| Treatment Outcome | 7 | 2023 | 10230 | 0.070 |
Why?
| Alcoholism | 1 | 2014 | 766 | 0.070 |
Why?
| Drug Prescriptions | 1 | 2009 | 248 | 0.070 |
Why?
| Medicaid | 3 | 2021 | 433 | 0.070 |
Why?
| Diabetes Mellitus | 2 | 2012 | 1001 | 0.070 |
Why?
| HIV Infections | 2 | 2013 | 2720 | 0.070 |
Why?
| Hospice Care | 2 | 2007 | 200 | 0.070 |
Why?
| Proxy | 1 | 2006 | 27 | 0.070 |
Why?
| Sex Factors | 3 | 2020 | 1968 | 0.060 |
Why?
| Employment | 1 | 2008 | 167 | 0.060 |
Why?
| Terminal Care | 2 | 2006 | 237 | 0.060 |
Why?
| Affect | 1 | 2008 | 286 | 0.060 |
Why?
| Kidney Diseases | 1 | 2009 | 384 | 0.060 |
Why?
| Social Support | 1 | 2010 | 588 | 0.060 |
Why?
| Vulnerable Populations | 1 | 2006 | 158 | 0.060 |
Why?
| Information Services | 1 | 2005 | 47 | 0.060 |
Why?
| Health Status Indicators | 1 | 2006 | 167 | 0.060 |
Why?
| Marital Status | 1 | 2005 | 44 | 0.060 |
Why?
| Direct Service Costs | 1 | 2004 | 10 | 0.060 |
Why?
| Patient Satisfaction | 2 | 2005 | 634 | 0.060 |
Why?
| Survivors | 1 | 2008 | 464 | 0.060 |
Why?
| Medical Assistance | 1 | 2004 | 10 | 0.060 |
Why?
| Smartphone | 1 | 2025 | 88 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2018 | 516 | 0.060 |
Why?
| Postal Service | 2 | 2018 | 33 | 0.060 |
Why?
| Health Services | 1 | 2005 | 99 | 0.060 |
Why?
| Odds Ratio | 3 | 2013 | 1023 | 0.050 |
Why?
| Forms and Records Control | 1 | 2004 | 22 | 0.050 |
Why?
| Vaccines, Combined | 1 | 2023 | 48 | 0.050 |
Why?
| Social Environment | 1 | 2005 | 292 | 0.050 |
Why?
| Socioeconomic Factors | 4 | 2011 | 1214 | 0.050 |
Why?
| Hypoglycemic Agents | 1 | 2012 | 1220 | 0.050 |
Why?
| Blood Component Transfusion | 1 | 2024 | 82 | 0.050 |
Why?
| Public Health Informatics | 1 | 2003 | 8 | 0.050 |
Why?
| Chickenpox Vaccine | 1 | 2023 | 71 | 0.050 |
Why?
| Hospices | 1 | 2004 | 89 | 0.050 |
Why?
| Colonoscopy | 1 | 2005 | 236 | 0.050 |
Why?
| Asthma | 4 | 2011 | 2230 | 0.050 |
Why?
| Comparative Effectiveness Research | 2 | 2015 | 149 | 0.050 |
Why?
| Ambulances | 1 | 2023 | 51 | 0.050 |
Why?
| Efficiency, Organizational | 1 | 2004 | 133 | 0.050 |
Why?
| Health Status | 1 | 2008 | 755 | 0.050 |
Why?
| Vaccines, Conjugate | 2 | 2018 | 63 | 0.050 |
Why?
| Ultrasonography, Prenatal | 2 | 2004 | 271 | 0.050 |
Why?
| Health Personnel | 2 | 2019 | 652 | 0.050 |
Why?
| Accidents, Traffic | 1 | 2023 | 186 | 0.050 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2022 | 41 | 0.050 |
Why?
| Kidney | 1 | 2009 | 1385 | 0.050 |
Why?
| Meconium | 1 | 2001 | 7 | 0.050 |
Why?
| Transplant Recipients | 1 | 2023 | 162 | 0.050 |
Why?
| Risk Reduction Behavior | 2 | 2017 | 209 | 0.050 |
Why?
| Meconium Aspiration Syndrome | 1 | 2001 | 11 | 0.050 |
Why?
| Mumps Vaccine | 1 | 2021 | 13 | 0.050 |
Why?
| Resuscitation | 1 | 2024 | 237 | 0.050 |
Why?
| Health Surveys | 2 | 2018 | 494 | 0.050 |
Why?
| Medicare | 2 | 2018 | 720 | 0.050 |
Why?
| Hospitals, Pediatric | 2 | 2015 | 509 | 0.050 |
Why?
| Feasibility Studies | 1 | 2025 | 868 | 0.050 |
Why?
| Nasopharynx | 1 | 2001 | 67 | 0.050 |
Why?
| Educational Status | 2 | 2017 | 470 | 0.050 |
Why?
| Health Policy | 1 | 2004 | 353 | 0.040 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 97 | 0.040 |
Why?
| Milk, Human | 1 | 2022 | 151 | 0.040 |
Why?
| Cooperative Behavior | 2 | 2015 | 433 | 0.040 |
Why?
| Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| Living Donors | 1 | 2023 | 287 | 0.040 |
Why?
| Body Composition | 1 | 2004 | 649 | 0.040 |
Why?
| Length of Stay | 3 | 2018 | 1127 | 0.040 |
Why?
| Intussusception | 2 | 2013 | 27 | 0.040 |
Why?
| Tetanus Toxoid | 2 | 2012 | 37 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2000 | 118 | 0.040 |
Why?
| Islets of Langerhans | 2 | 1996 | 791 | 0.040 |
Why?
| New York | 1 | 2020 | 128 | 0.040 |
Why?
| Animals | 3 | 2019 | 35361 | 0.040 |
Why?
| Prognosis | 3 | 2017 | 3794 | 0.040 |
Why?
| Pandemics | 2 | 2021 | 1488 | 0.040 |
Why?
| Age Distribution | 2 | 2013 | 372 | 0.040 |
Why?
| Infant Formula | 2 | 2010 | 74 | 0.040 |
Why?
| Blood Flow Velocity | 1 | 2000 | 404 | 0.040 |
Why?
| Fetal Growth Retardation | 1 | 2004 | 550 | 0.040 |
Why?
| Outpatient Clinics, Hospital | 2 | 2011 | 82 | 0.040 |
Why?
| Serogroup | 1 | 2018 | 33 | 0.040 |
Why?
| Pharmacists | 1 | 2021 | 247 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2017 | 1952 | 0.040 |
Why?
| Hospital Charges | 1 | 2018 | 41 | 0.040 |
Why?
| Colorectal Neoplasms | 1 | 2005 | 752 | 0.040 |
Why?
| Comorbidity | 2 | 2013 | 1547 | 0.040 |
Why?
| HLA Antigens | 2 | 1996 | 234 | 0.040 |
Why?
| Diphtheria | 1 | 2017 | 20 | 0.040 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2018 | 69 | 0.040 |
Why?
| Morbidity | 1 | 2019 | 302 | 0.040 |
Why?
| Tetanus | 1 | 2017 | 25 | 0.040 |
Why?
| Patient Discharge | 1 | 2004 | 857 | 0.040 |
Why?
| Pilot Projects | 2 | 2015 | 1587 | 0.040 |
Why?
| Awareness | 1 | 2018 | 100 | 0.040 |
Why?
| Chest Pain | 1 | 2018 | 89 | 0.040 |
Why?
| Whooping Cough | 1 | 2017 | 49 | 0.040 |
Why?
| Immunization, Secondary | 2 | 2010 | 87 | 0.030 |
Why?
| Population Groups | 1 | 2017 | 60 | 0.030 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2020 | 232 | 0.030 |
Why?
| Healthy Lifestyle | 1 | 2017 | 32 | 0.030 |
Why?
| Demography | 2 | 2008 | 279 | 0.030 |
Why?
| Transplantation Immunology | 1 | 2017 | 34 | 0.030 |
Why?
| Lipoproteins, LDL | 1 | 2017 | 127 | 0.030 |
Why?
| Medication Adherence | 2 | 2012 | 558 | 0.030 |
Why?
| Palivizumab | 1 | 2016 | 13 | 0.030 |
Why?
| Health Plan Implementation | 1 | 2018 | 137 | 0.030 |
Why?
| Cost of Illness | 1 | 2018 | 278 | 0.030 |
Why?
| Professional Practice Gaps | 1 | 2016 | 15 | 0.030 |
Why?
| Milk Proteins | 1 | 1996 | 33 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2017 | 148 | 0.030 |
Why?
| Altitude | 1 | 2000 | 461 | 0.030 |
Why?
| Administration, Oral | 1 | 1998 | 786 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2017 | 422 | 0.030 |
Why?
| Milk | 1 | 1996 | 120 | 0.030 |
Why?
| Liver Failure | 1 | 2016 | 91 | 0.030 |
Why?
| Equipment and Supplies | 1 | 2015 | 41 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 1996 | 3628 | 0.030 |
Why?
| Contrast Media | 1 | 2018 | 394 | 0.030 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2015 | 62 | 0.030 |
Why?
| Canada | 1 | 2016 | 350 | 0.030 |
Why?
| Immunocompromised Host | 1 | 2017 | 198 | 0.030 |
Why?
| Focus Groups | 1 | 2017 | 453 | 0.030 |
Why?
| Exercise Test | 1 | 2018 | 613 | 0.030 |
Why?
| Retreatment | 1 | 2015 | 70 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 248 | 0.030 |
Why?
| Triglycerides | 1 | 2017 | 527 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 122 | 0.030 |
Why?
| Ventricular Outflow Obstruction | 1 | 2015 | 40 | 0.030 |
Why?
| Mass Screening | 2 | 2005 | 1149 | 0.030 |
Why?
| Heart Rate | 1 | 2018 | 802 | 0.030 |
Why?
| Graft Survival | 1 | 2017 | 512 | 0.030 |
Why?
| Unemployment | 1 | 2014 | 43 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 482 | 0.030 |
Why?
| Consumer Behavior | 1 | 2014 | 67 | 0.030 |
Why?
| Bisexuality | 1 | 2013 | 30 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2021 | 2717 | 0.030 |
Why?
| Homosexuality, Female | 1 | 2013 | 39 | 0.030 |
Why?
| Unsafe Sex | 1 | 2013 | 58 | 0.030 |
Why?
| Communication | 1 | 2019 | 846 | 0.030 |
Why?
| Decision Support Systems, Clinical | 1 | 2016 | 205 | 0.030 |
Why?
| Societies, Medical | 1 | 2017 | 751 | 0.030 |
Why?
| Circovirus | 1 | 2013 | 7 | 0.030 |
Why?
| Graft Rejection | 1 | 2017 | 598 | 0.030 |
Why?
| Social Behavior | 1 | 2015 | 289 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 1838 | 0.030 |
Why?
| Community Mental Health Services | 1 | 2013 | 89 | 0.030 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 430 | 0.030 |
Why?
| Housing | 1 | 2014 | 130 | 0.030 |
Why?
| Drug Contamination | 1 | 2013 | 51 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2014 | 186 | 0.030 |
Why?
| Sex Distribution | 1 | 2013 | 359 | 0.030 |
Why?
| Product Surveillance, Postmarketing | 1 | 2013 | 62 | 0.020 |
Why?
| Autoimmune Diseases | 1 | 1996 | 426 | 0.020 |
Why?
| Hospital Mortality | 1 | 1997 | 850 | 0.020 |
Why?
| Homosexuality, Male | 1 | 2013 | 175 | 0.020 |
Why?
| Patient Compliance | 2 | 2012 | 565 | 0.020 |
Why?
| Autoantibodies | 2 | 1996 | 1466 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2012 | 95 | 0.020 |
Why?
| Databases, Factual | 1 | 2017 | 1269 | 0.020 |
Why?
| Self Report | 1 | 2016 | 799 | 0.020 |
Why?
| Double-Blind Method | 1 | 2015 | 1876 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 81 | 0.020 |
Why?
| Qualitative Research | 1 | 2017 | 1235 | 0.020 |
Why?
| Autoimmunity | 1 | 1996 | 862 | 0.020 |
Why?
| Interpersonal Relations | 1 | 2014 | 392 | 0.020 |
Why?
| Fees, Pharmaceutical | 1 | 2010 | 10 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2011 | 113 | 0.020 |
Why?
| Swine | 1 | 2013 | 760 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2012 | 358 | 0.020 |
Why?
| Fees, Medical | 1 | 2009 | 9 | 0.020 |
Why?
| Drug Utilization | 1 | 2011 | 171 | 0.020 |
Why?
| Multilingualism | 1 | 2009 | 26 | 0.020 |
Why?
| Gestational Age | 2 | 2004 | 874 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2012 | 1206 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 61 | 0.020 |
Why?
| Electronic Health Records | 1 | 2016 | 975 | 0.020 |
Why?
| Telephone | 1 | 2010 | 167 | 0.020 |
Why?
| Caregivers | 2 | 2006 | 815 | 0.020 |
Why?
| Community-Based Participatory Research | 1 | 2009 | 148 | 0.020 |
Why?
| Epidemiologic Research Design | 1 | 2008 | 28 | 0.020 |
Why?
| Diabetes Complications | 1 | 2009 | 224 | 0.020 |
Why?
| Single-Blind Method | 1 | 2008 | 271 | 0.020 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2009 | 137 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 3083 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 2012 | 0.020 |
Why?
| Health Care Rationing | 1 | 2007 | 57 | 0.020 |
Why?
| Psychology | 1 | 2008 | 82 | 0.020 |
Why?
| Blood Glucose | 1 | 2017 | 2097 | 0.020 |
Why?
| Vascular Diseases | 1 | 2009 | 241 | 0.020 |
Why?
| Office Visits | 1 | 2006 | 85 | 0.020 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 1996 | 45 | 0.020 |
Why?
| Glutamate Decarboxylase | 2 | 1996 | 166 | 0.020 |
Why?
| Insulin Antibodies | 2 | 1996 | 105 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2009 | 711 | 0.020 |
Why?
| Psychosocial Deprivation | 1 | 2005 | 5 | 0.020 |
Why?
| Health Behavior | 1 | 2011 | 741 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2010 | 743 | 0.010 |
Why?
| Protein Tyrosine Phosphatases | 2 | 1996 | 168 | 0.010 |
Why?
| Urban Health | 1 | 2005 | 79 | 0.010 |
Why?
| Biomarkers | 2 | 2012 | 3973 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2009 | 1295 | 0.010 |
Why?
| Rural Health | 1 | 2005 | 70 | 0.010 |
Why?
| Medical Staff, Hospital | 1 | 2005 | 78 | 0.010 |
Why?
| Prostatectomy | 1 | 2005 | 106 | 0.010 |
Why?
| Mass Media | 1 | 2005 | 40 | 0.010 |
Why?
| Karnofsky Performance Status | 1 | 2004 | 38 | 0.010 |
Why?
| Time and Motion Studies | 1 | 2004 | 21 | 0.010 |
Why?
| Brachytherapy | 1 | 2005 | 104 | 0.010 |
Why?
| Biometry | 1 | 2004 | 69 | 0.010 |
Why?
| Probability | 1 | 2005 | 306 | 0.010 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 253 | 0.010 |
Why?
| Ohio | 1 | 2004 | 152 | 0.010 |
Why?
| Professional-Patient Relations | 1 | 2005 | 140 | 0.010 |
Why?
| Perception | 1 | 2007 | 340 | 0.010 |
Why?
| Feeding Behavior | 1 | 2009 | 624 | 0.010 |
Why?
| Body Size | 1 | 2004 | 102 | 0.010 |
Why?
| Internship and Residency | 1 | 2013 | 1053 | 0.010 |
Why?
| Policy Making | 1 | 2004 | 88 | 0.010 |
Why?
| Eligibility Determination | 1 | 2004 | 63 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1501 | 0.010 |
Why?
| Patient Care | 1 | 2004 | 109 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2011 | 2742 | 0.010 |
Why?
| Femur | 1 | 2004 | 244 | 0.010 |
Why?
| Mortality | 1 | 2004 | 307 | 0.010 |
Why?
| Recurrence | 1 | 2005 | 1007 | 0.010 |
Why?
| Apgar Score | 1 | 2001 | 16 | 0.010 |
Why?
| Perineum | 1 | 2001 | 26 | 0.010 |
Why?
| Bone and Bones | 1 | 2004 | 299 | 0.010 |
Why?
| Suction | 1 | 2001 | 32 | 0.010 |
Why?
| Endpoint Determination | 1 | 2001 | 76 | 0.010 |
Why?
| Delivery, Obstetric | 1 | 2001 | 137 | 0.010 |
Why?
| Umbilical Cord | 1 | 2000 | 83 | 0.010 |
Why?
| Private Sector | 1 | 2000 | 50 | 0.010 |
Why?
| Patient Readmission | 1 | 2004 | 667 | 0.010 |
Why?
| Arteries | 1 | 2000 | 265 | 0.010 |
Why?
| Exercise | 1 | 2009 | 1925 | 0.010 |
Why?
| Birth Weight | 1 | 2000 | 505 | 0.010 |
Why?
| Acute Disease | 1 | 2000 | 980 | 0.010 |
Why?
| Histocompatibility Testing | 1 | 1996 | 120 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 163 | 0.010 |
Why?
| Infant Food | 1 | 1996 | 65 | 0.010 |
Why?
| HLA-DQ Antigens | 1 | 1996 | 179 | 0.010 |
Why?
| Dietary Proteins | 1 | 1996 | 129 | 0.010 |
Why?
| DNA Primers | 1 | 1996 | 510 | 0.010 |
Why?
| HLA-DR Antigens | 1 | 1996 | 224 | 0.010 |
Why?
| Fetal Blood | 1 | 1996 | 316 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1996 | 1038 | 0.010 |
Why?
| Alleles | 1 | 1996 | 845 | 0.010 |
Why?
| Survival Analysis | 1 | 1996 | 1274 | 0.010 |
Why?
| Genotype | 1 | 1996 | 1839 | 0.010 |
Why?
|
|
Beaty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|